Endo International Bankruptcy & Opioid Crisis Misconduct Explained

TL;DR Endo International, a pharmaceutical giant that manufactured and sold opioids to millions of Americans, filed for Chapter 11 bankruptcy in 2022 after accumulating more than $4.5 trillion in deemed opioid claims from states, cities, tribes, hospitals, schools, and individualβ¦








